Pediatrix Medical Group (FRA:PDC) Equivalent Admissions #: 0.00 (As of . 20)


FRA:PDC Pediatrix Medical Group Inc FRA:PDC
57 GF Score
Price €23.20
GF Value €11.10
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pediatrix Medical Group Equivalent Admissions #?

Pediatrix Medical Group FRA:PDC +1.75% 57 Equivalent Admissions # is 0.00 as of . 20. GuruFocus rates FRA:PDC with a GF Score™ of 57/100 and a GF Value™ of €11.10 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for Pediatrix Medical Group's Equivalent Admissions # or its related term are showing as below:

FRA:PDC's Equivalent Admissions # is not ranked *
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

Pediatrix Medical Group Equivalent Admissions # Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group Equivalent Admissions # Chart


FRA:PDC
57GF Score
Pediatrix Medical Group Inc FRA:PDC
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Equivalent Admissions # of 0.00 mean?
Pediatrix Medical Group (FRA:PDC) has a Equivalent Admissions # of 0.00 as of . 20. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Pediatrix Medical Group and its competitors.
Is Pediatrix Medical Group's Equivalent Admissions # too high?
Pediatrix Medical Group's current Equivalent Admissions # is 0.00. Overall, Pediatrix Medical Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Equivalent Admissions # compare to SEM and AGL?
Pediatrix Medical Group's Equivalent Admissions # of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Healthcare Providers & Services company?
A good Equivalent Admissions # depends on the Healthcare Providers & Services industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Pediatrix Medical Group and its competitors. Pediatrix Medical Group's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.10, compared to a current price of €23.20 — trading 109% above its estimated fair value. The current Equivalent Admissions # is 0.00. Pediatrix Medical Group's overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Equivalent Admissions # is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of €23.20 is trading 109% above its estimated GF Value™ of €11.10. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for FRA:PDC:

  • Equivalent Admissions #: 0.00
  • GF Value™: €11.10 vs. price of €23.20 (109% above fair value)
  • GF Score™: 57/100 with 8 warning signs

No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pediatrix Medical Group Business Description

Other Exchanges MD:USA
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
57GF Score

Get the complete analysis for FRA:PDC

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.20
Price
€11.10
GF Value